Self-Efficacy and the Impact of Inflammatory Bowel Disease on Patients' Daily Lives

• Published in: Clinical and translational gastroenterology Vol. 14; no. 6; p. e00577
• Main Authors: Sheehan, Jessica L., Greene-Higgs, LaVana, Swanson, Linnea, Higgins, Peter D.R., Krein, Sarah L., Waljee, Akbar K., Saini, Sameer D., Berinstein, Jeffrey A., Mellinger, Jessica L., Piette, John D., Resnicow, Ken, Cohen-Mekelburg, Shirley
• Format: Journal Article
• Language: English
• Published: United States Wolters Kluwer 01-06-2023
• Subjects: Adaptation, Psychological; Anxiety - etiology; Humans; Inflammatory Bowel Disease; Inflammatory Bowel Diseases - complications; Inflammatory Bowel Diseases - therapy; Quality of Life - psychology; Self Efficacy
• ISSN: 2155-384X; 2155-384X
• DOI: 10.14309/ctg.0000000000000577

Self-efficacy, i.e., the confidence in one's capacity to perform a behavior, is crucial to the development of inflammatory bowel disease (IBD) self-management skills. We aimed to measure IBD self-efficacy and the relationship between self-efficacy and the patient-reported impact of IBD on daily life.
We surveyed patients with IBD from a single academic center using the IBD Self-Efficacy Scale (IBD-SES) and patient-reported outcome (PRO) measures. The IBD-SES assesses 4 IBD domains: patients' confidence in managing stress and emotions, symptoms and disease, medical care, and remission. IBD PROs evaluate daily life impact, coping strategies, emotional impact, and systemic symptoms. We examined the association between IBD-SES domains with the lowest scores and IBD daily life impact.
A total of 160 patients completed the survey. Domain scores on the IBD-SES were lowest for managing stress and emotions (mean 6.76, SD 1.86) and symptoms and disease (mean 6.71, SD 2.12) on a 1-10 scale. Controlling for age, sex, IBD type, disease activity, moderate-to-severe disease, depression and anxiety, a higher confidence in managing stress and emotions (β -0.12, 95% confidence interval -0.20 to -0.05, P = 0.001), and managing symptoms and disease (β -0.28, 95% confidence interval -0.35 to -0.20, P < 0.001) were each associated with lower IBD daily life impact.
Patients with IBD report low confidence in managing stress and emotion and managing symptoms and disease. Higher self-efficacy in these domains was associated with lower IBD daily life impact. Self-management tools that promote self-efficacy in managing these domains have the potential to reduce IBD's daily life impact.